Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
作者信息
Bommer J, Huber W, Tewes G, Ritz E, von Wedel S, Küppers S, Weinreich T, Bommer G
机构信息
Medizinische Universitätsklinik, Heidelberg, BRD.
出版信息
Contrib Nephrol. 1988;66:131-8. doi: 10.1159/000416011.
PMID:3391027
Abstract
摘要
相似文献
1
Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin.
Contrib Nephrol. 1988;66:131-8. doi: 10.1159/000416011.
2
Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.甲状旁腺功能亢进治疗后慢性肾衰竭贫血的演变
Nephron. 1996;74(2):444-5. doi: 10.1159/000189359.
3
Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin.接受重组人促红细胞生成素的血液透析患者的淋巴细胞亚群和迟发型皮肤超敏反应
Contrib Nephrol. 1988;66:195-204. doi: 10.1159/000416018.
4
Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin.接受重组人促红细胞生成素治疗前后规律透析患者的尿素动力学
Contrib Nephrol. 1988;66:149-55. doi: 10.1159/000416013.
5
Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.血液流变学在接受重组人促红细胞生成素治疗肾性贫血的血液透析患者高血压发病机制中的作用。
Contrib Nephrol. 1990;82:79-85. doi: 10.1159/000418721.
6
Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.重组人促红细胞生成素纠正维持性血液透析患者贫血的有益和不良影响。
Contrib Nephrol. 1988;66:104-13. doi: 10.1159/000416008.
7
Erythropoietin for anemia of renal failure in sickle cell disease.促红细胞生成素用于镰状细胞病肾衰竭贫血
N Engl J Med. 1991 May 9;324(19):1369-70. doi: 10.1056/NEJM199105093241916.
8
Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.通过血清促红细胞生成素检测监测慢性肾衰竭贫血的促红细胞生成素治疗。
Ann Clin Biochem. 1993 Mar;30 ( Pt 2):205-6. doi: 10.1177/000456329303000219.
9
10
[Erythropoietin: the significance in therapeutic system of renal failure; clinical efficacy of erythropoietin].[促红细胞生成素：在肾衰竭治疗体系中的意义；促红细胞生成素的临床疗效]
Nihon Jinzo Gakkai Shi. 1989 May;31(5):435-9.
引用本文的文献
1
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.促红细胞生成素（重组人促红细胞生成素）。对其药效学和药代动力学特性以及在贫血和刺激红细胞生成方面的治疗潜力的综述。
Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004.
Zotero 插件